Alexandria Real Estate Equities
ARE
#2386
Rank
$7.78 B
Marketcap
$44.70
Share price
-2.57%
Change (1 day)
-17.62%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

EPS for Alexandria Real Estate Equities (ARE)

EPS in 2023 (TTM): $1.39

According to Alexandria Real Estate Equities 's latest financial reports the company's current EPS (TTM) is -$8.42. In 2022 the company made an earnings per share (EPS) of $3.13 a decrease over its 2021 EPS that were of $3.79.

EPS history for Alexandria Real Estate Equities from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.39-55.59%
2022$3.13-17.41%
2021$3.79-35.32%
2020$5.8689.03%
2019$3.10-12.68%
2018$3.55124.68%
2017$1.58-179%
2016-$2.00-221.95%
2015$1.6462.38%
2014$1.01-36.87%
2013$1.6046.79%
2012$1.09-36.63%
2011$1.72-20.74%
2010$2.17-21.66%
2009$2.77-3.48%
2008$2.878.3%
2007$2.6516.23%
2006$2.280.88%
2005$2.26-9.27%
2004$2.49-23.36%
2003$3.2581.56%
2002$1.797.19%
2001$1.67-7.22%
2000$1.8021.62%
1999$1.48-8.07%
1998$1.61-217.81%
1997-$1.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
$0.71-108.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$30.89-466.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$17.38-306.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-$3.10-63.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$5.89-169.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$4.52-153.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
$19.81-335.27%๐Ÿ‡บ๐Ÿ‡ธ USA